"Our body is very well capable of recreating cartilage, but we need to give it a little bit of a help", Leo Smit (CEO Hy2Care®) at the @MedTechStrat summit (Dublin). Watch the full video pitch here: https://t.co/ZMMB5DvnJ9 #InnovationDublin2024
MedTech Strategist is honored to welcome @Hy2Care alongside CEO Leo Smit as a Presenting Company at the 10th Annual Innovation Summit Dublin 2024.
Welcome to #InnovationDublin24, Leo and Hy2Care® BV!
Join Leo Smit, CEO of Hy2Care®, on Wednesday, 20 March 2024 during the LSI USA ’24 Event. Leo will share the story of Hy2Care's CartRevive™ hydrogel implant, the game-changer in the long-standing clinical challenge of lasting cartilage repair. @lsintelligence#LSIUSA24
During the LSI USA '24 event in California, CEO Hy2Care Leo Smit will share the story of Hy2Care's CartRevive™ hydrogel implant for optimal cartilage repair in the knee. If you are interested in meeting Leo, please contact us.
@lsintelligence#LSIUSA24
The Dutch magazine @de_ingenieur interviewed Leo Smit, CEO Hy2Care® and Sanna Severins, COO Hy2Care® about Hy2Care’s hydrogel implant developed to enable cartilage repair in the knee. Read the article in Dutch here: https://t.co/1z9uNFuLYR #cartilageregeneration#orthotwitter
This week, Sanna Severins (COO Hy2Care®) and Leo Smit (CEO Hy2Care®) were present at the HealthTech Investor Summit (Buges), sharing the story of Hy2Care’s CartRevive™ hydrogel implant, a game-changer in the long-standing clinical challenge of lasting #cacartilagerepair
Next week, the #hy2Care team will attend the @MEDICATradeFair. They are excited to meet you and provide more information about Hy2Care's CartRevive™ #hydrogeltechnology for #cartilagerepair. Feel free to contact us to schedule an appointment. We hope to meet you next week!
Meet Hy2Care at the LSX Inv€$tival in London. On 13 November, (CEO Hy2Care) will will pitch Hy2Care's story about its CartRevive™ hydrogel implant for cartilage repair. Hope to meet you there! #medtech#healthtech#cartilageregeneration@LSXLeaders
Watch the video from the recent LSI Emerging MedTech Summit in Barcelona, where Leo Smit, CEO of Hy2Care, introduced Hy2Care’s CartRevive™ hydrogel implant to a public of leading #healthcare#investors: watch the full pitch here: https://t.co/eaVYx3WALM @lsintelligence
Hy2Care® receives #FDA Breakthrough Device Designation for its CartRevive™ hydrogel implant, marking a significant step in #cartilagerepair. Read the press release: https://t.co/LS600418ZD #cartialageregeneration#FDAApproval
“The myth that cartilage cannot heal, has been busted” Were the words of our CEO Leo Smit, during the Life Science Intelligence conference last week. “CARTilage can REVIVE in an optimized environment. Hy2Care's CartRevive™ hydrogel implant is that game-changer."
@lsintelligence
This week, the first results of Hy2Care’s CartRevive™ hydrogel implant were presented at the @CartilageRepair World Congress by the primary clinical investigators of our ACTIVE study. Download the paper here: https://t.co/pYqRq9IOoC @UMCUtrecht@UTwente#cartilageregeneration
Meet our team at the ICRS congress 2023 in Barcelona next week to hear more about Hy2Care’s CartRevive™ hydrogel implant, aimed to facilitate the repair of traumatic #cartilagedefects. Feel free to contact us to schedule a personal meeting. @CartilageRepair
Hy2Care has started with the 2nd phase of its #clinicalstudy enabling optimal #cartilagerepair in the knee. This year, 36 patients can be treated with the CartRevive™ hydrogel implant. Read more about the criteria to participate in the study: https://t.co/bHc1lYSsZf
Hy2care starts with 2nd phase ACTIVE #clinicalstudy to improve #cartilagerepair in the knee. The Medical Ethical Review Committee of @UMCUtrecht has granted approval to continue the study, which will be conducted by @UMC Utrecht @MaastrichtUMC, @ETZnl: https://t.co/D0WdF8F5zD
HAPPY NEW YEAR! What are your plans for 2023? We will continue our journey with Hy2Care’s unique hydrogel to repair early #cartilagedamage in the knee. Part of this journey is the 2nd phase of the #clinicaltrial. More info soon #cartilageregeneration
2022 has been a memorable year. We have started our #clinicaltrial, received major funding from the EU Horizon 2020 – EIC Accelerator program and we have welcomed several new team members. Now it is time to relax and prepare for a new and exciting 2023. Happy holidays!
Kijk en luister hier het interview van Marcel Karperien, CSO #Hy2Care in het programma @VillaVdb waarin hij vertelt over de nieuwe kraakbeentechnologie om #kraakbeenschade in de knie te herstellen #stopartrose
Come and visit the Brightlands #exposition, an initiative of @BL_Chemelot and Yksi Connect to showcase innovations in the area of sustainability and health. For #Hy2Care a great spot to give exposure to its solution for early #cartilagedamage; enabling the body to heal itself.
A warm welcome to two new colleagues in the #Hy2Care team! Johan Jansen joined us last month as Chief Financial Officer and Kim Sondeijker started this week as Project and Operations Manager. Congratulations and lots of success. Meet our full team here: https://t.co/EQCZh1JUHb